Contemporary seasonal influenza A (H1N1) virus infection primes for a more robust response to split inactivated pandemic influenza A (H1N1) virus vaccination in ferrets

Clinical and Vaccine Immunology

Volumn 17, Issue 12, 2010, Pages 1998-2006

  Ellebedy, Ali H ^a   Fabrizio, Thomas P ^a   Kayali, Ghazi ^a   Oguin III, Thomas H ^a   Brown, Scott A ^a   Rehg, Jerold ^a   Thomas, Paul G ^a   Webby, Richard J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FERRET; INFLUENZA A (H1N1); LUNG PARENCHYMA; MORBIDITY; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; SEASONAL INFLUENZA; SINGLE DRUG DOSE; VACCINATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; FERRETS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION; VACCINES, SUBUNIT;

EID: 78649864342     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00247-10     Document Type: Article

References (25)

1. Alexander, D. J., and I. H. Brown. 2000. Recent zoonoses caused by influenza A viruses. Rev. Sci. Tech. 19:197-225.
2. Anonymous. 2009. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb. Mortal. Wkly. Rep. 58:400-402.
3. Anonymous. 2009. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recommend. Rep. 58:1-8.
4. Anonymous. 2009. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58:521-524.
5. Atmar, R. L., W. A. Keitel, S. M. Patel, J. M. Katz, D. She, H. El Sahly, J. Pompey, T. R. Cate, and R. B. Couch. 2006. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin. Infect. Dis. 43:1135-1142.
6. Clark, T. W., M. Pareek, K. Hoschler, H. Dillon, K. G. Nicholson, N. Groth, and I. Stephenson. 2009. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361:2424-2435.
7. Dawood, F. S., S. Jain, L. Finelli, M. W. Shaw, S. Lindstrom, R. J. Garten, L. V. Gubareva, X. Xu, C. B. Bridges, and T. M. Uyeki. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615.
8. De Groot, A. S., M. Ardito, E. M. McClaine, L. Moise, and W. D. Martin. 2009. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 27:5740-5747.
9. Del Giudice, G., K. J. Stittelaar, G. van Amerongen, J. Simon, A. D. Osterhaus, K. Stohr, and R. Rappuoli. 2009. Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci. Transl. Med. 1:12re1.
10. Echevarria-Zuno, S., J. M. Mejia-Arangure, A. J. Mar-Obeso, C. Grajales-Muniz, E. Robles-Perez, M. Gonzalez-Leon, M. C. Ortega-Alvarez, C. Gonzalez-Bonilla, R. A. Rascon-Pacheco, and V. H. Borja-Aburto. 2009. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 374:2072-2079.
11. Garten, R. J., C. T. Davis, C. A. Russell, B. Shu, S. Lindstrom, A. Balish, W. M. Sessions, X. Xu, E. Skepner, V. Deyde, M. Okomo-Adhiambo, L. Gubareva, J. Barnes, C. B. Smith, S. L. Emery, M. J. Hillman, P. Rivailler, J. Smagala, M. de Graaf, D. F. Burke, R. A. Fouchier, C. Pappas, C. M. Alpuche-Aranda, H. Lopez-Gatell, H. Olivera, I. Lopez, C. A. Myers, D. Faix, P. J. Blair, C. Yu, K. M. Keene, P. D. Dotson, Jr., D. Boxrud, A. R. Sambol, S. H. Abid, K. St. George, T. Bannerman, A. L. Moore, D. J. Stringer, P. Blevins, G. J. Demmler-Harrison, M. Ginsberg, P. Kriner, S. Waterman, S. Smole, H. F. Guevara, E. A. Belongia, P. A. Clark, S. T. Beatrice, R. Donis, J. Katz, L. Finelli, C. B. Bridges, M. Shaw, D. B. Jernigan, T. M. Uyeki, D. J. Smith, A. I. Klimov, and N. J. Cox. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
12. Ge, X., V. Tan, P. L. Bollyky, N. E. Standifer, E. A. James, and W. W. Kwok. 2010. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J. Virol. 84:3312-3319.
13. Govorkova, E. A., R. J. Webby, J. Humberd, J. P. Seiler, and R. G. Webster. 2006. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J. Infect. Dis. 194:159-167.
14. Greenbaum, J. A., M. F. Kotturi, Y. Kim, C. Oseroff, K. Vaughan, N. Salimi, R. Vita, J. Ponomarenko, R. H. Scheuermann, A. Sette, and B. Peters. 2009. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. U. S. A. 106:20365-20370.
15. Greenberg, M. E., M. H. Lai, G. F. Hartel, C. H. Wichems, C. Gittleson, J. Bennet, G. Dawson, W. Hu, C. Leggio, D. Washington, and R. L. Basser. 2009. Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med. 361:2405-2413.
16. Lipatov, A. S., E. Hoffmann, R. Salomon, H. L. Yen, and R. G. Webster. 2006. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/ 97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J. Infect. Dis. 194:1040-1043.
17. Ochi, A., A. Danesh, C. Seneviratne, D. Banner, M. E. Devries, T. Rowe, L. Xu, L. Ran, M. Czub, S. E. Bosinger, M. J. Cameron, C. M. Cameron, and D. J. Kelvin. 2008. Cloning, expression and immunoassay detection of ferret IFN-gamma. Dev. Comp. Immunol. 32:890-897.
18. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
19. Rutigliano, J. A., P. C. Doherty, J. Franks, M. Y. Morris, C. Reynolds, and P. G. Thomas. 2008. Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection. J. Immunol. Methods 336:71-77.
20. Smith, G. J., J. Bahl, D. Vijaykrishna, J. Zhang, L. L. Poon, H. Chen, R. G. Webster, J. S. Peiris, and Y. Guan. 2009. Dating the emergence of pandemic influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 106:11709-11712.
21. Smith, G. J., D. Vijaykrishna, J. Bahl, S. J. Lycett, M. Worobey, O. G. Pybus, S. K. Ma, C. L. Cheung, J. Raghwani, S. Bhatt, J. S. Peiris, Y. Guan, and A. Rambaut. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125.
22. Treanor, J. J., J. D. Campbell, K. M. Zangwill, T. Rowe, and M. Wolff. 2006. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N. Engl. J. Med. 354:1343-1351.
23. Webby, R. J., and R. G. Webster. 2003. Are we ready for pandemic influenza? Science 302:1519-1522.
24. Wei, C. J., J. C. Boyington, K. Dai, K. V. Houser, M. B. Pearce, W. P. Kong, Z. Y. Yang, T. M. Tumpey, and G. J. Nabel. 2010. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2:24ra21.
25. Zhu, F. C., H. Wang, H. H. Fang, J. G. Yang, X. J. Lin, X. F. Liang, X. F. Zhang, H. X. Pan, F. Y. Meng, Y. M. Hu, W. D. Liu, C. G. Li, W. Li, X. Zhang, J. M. Hu, W. B. Peng, B. P. Yang, P. Xi, H. Q. Wang, and J. S. Zheng. 2009. A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med. 361:2414-2423.